Autoinflammatory & rare systemic diseases

Targeting neutrophil-driven inflammation in adult-onset still’s disease: molecular insights from gene expression profiles

Arthritis Res TherPublished Mechanistic study

Authors' conclusion

Neutrophil activation is a key pathological module in AOSD.

Study context

Population
Blood transcriptomic dataset of patients with adult-onset Still's disease (AOSD) and healthy controls
Participants
31 vs 22
Comparison
AOSD vs healthy controls
  • AOSDn = 31
  • Healthy controlsn = 22reference
Outcome
Blood molecular signatures and molecular targets for neutrophil activation
Methodological detailsblood transcriptomic dataset, differentially expressed genes and functional enrichment analysis, kernel-based diffusion scoring
  • Blood transcriptomic dataset
  • Differentially expressed genes and functional enrichment analysis
  • Kernel-based diffusion scoring

Main finding

As reported in the abstract

  • Neutrophil degranulation is the most enriched pathological process in AOSD
  • Neutrophil degranulation correlated significantly with expression of Fcγ receptors, IL-1 receptors and chemokine receptors and their signalling activities
  • IL-1 inhibitors and IL-6 inhibitors did not show a diffusion score favourable for directly deactivating neutrophil degranulation
  • Agents targeting CXCR1/CXCR2, C5AR1, neutrophil elastase, SRC and SYK showed significant diffusion scores for neutrophil degranulation
  • CXCR1, CXCR2 and C5AR1 were differentially expressed genes (DEGs) predominantly expressed in neutrophils and closely associated with neutrophil degranulation in context-specific functional analysis

Original publication

Targeting neutrophil-driven inflammation in adult-onset still’s disease: molecular insights from gene expression profiles. Arthritis Res Ther. Published 1 July 2025. doi:10.1186/s13075-025-03598-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.